Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Nexavar in patients from prior Bayer/Onyx sorafenib trials
CTR20131621Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sorafenib in cancer, sponsored by Bayer. Started Apr 2014; status: completed.
02
Drugs
sorafenib
03
Conditions
cancer
Beyond the preview
Go deeper on CTR20131621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131621.